Indication
Early Course Schizophrenia Spectrum Disorder
1 clinical trial
1 product
Product
CVL-562Clinical trial
A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for SchizophreniaStatus: Active (not recruiting), Estimated PCD: 2024-03-22